Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Revenue Performance and Segment Results
A logo

Agilent Achieves 7% Revenue Growth to $1.8 Billion Amid Market Recovery

A10-QFiling Date: 3/3/2026
Agilent Technologies, Inc.
Description

What this story covers

Agilent Technologies reported a 7% revenue increase to $1,798 million, driven by a recovery in pharmaceutical spending. Despite margin pressure from tariffs and restructuring, strong liquidity and strategic investments in therapeutic manufacturing signal a resilient long-term outlook.

Story snapshot

CompanyAgilent Technologies, Inc.
TickerA
VariantStandard detailed
Duration10:35
Filing type10-Q
PeriodQ1 2026
IndustryHealthcare & Pharmaceuticals
Accession0001090872-26-000023
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-QView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in